The Future of Lung Cancer Starts Here
Read time: 1 minute. For more than two decades, LUNGevity Foundation has been a leader in advancing lung cancer research. Since 2002, we have invested $55+ million in more than 200
RESEARCH BLOG Blogs
-
-
Biggest News from Berlin: Research Highlights from ESMO
Read time: 5 minutes. Lung cancer research was in the spotlight at the European Society for Medical Oncology (ESMO) meeting held October 17-21, 2025, in Berlin, Germany. With -
LUNGevity Foundation Invests $1.2 Million to Fuel Next Generation of Lung Cancer Research
Read time: 6 minutes. LUNGevity Foundation announced $1.2 million in research awards that are designed to strengthen the lung cancer workforce and accelerate progress across the -
Reaping the Rewards of Radiation to Make Immunotherapy More Effective
Read time: 3 minutes. Immune checkpoint inhibitors (ICIs) have revolutionized the way we approach lung cancer treatment over the past decade. These lifesaving drugs block the PD-L1 -
Aiming for a Cure: How CD74 Research Could Eliminate Drug-Resistant Lung Cancer for Good
Read time: 4 minutes. Lung cancer remains the leading cause of cancer death worldwide. Over the past two decades, the development of targeted therapies, particularly tyrosine -
Researcher Goes Against the Grain: Brings New Hope for Patients with BRAF Fusions
Read time: 4 minutes. BRAF is an important signaling protein that regulates how normal cells grow and multiply through the MAPK (mitogen activated protein kinase) signaling pathway -
Advancing Lung Cancer Screening in Veterans Through Strategic Research
Read time: 4 minutes. Lung cancer screening has the potential to save more lives than any other cancer screening tool, yet reports suggest only 10%–20% of eligible patients are -
Low-Dose Computed Tomography and Beyond: Advances in the Early Detection of Lung Cancer
Read time: 5 minutes. Lung cancer screening has come a long way since low-dose CT (LDCT) scans first became available in 2015 in the United States. However, LDCTs can still miss -
New Insights in Treating Metastatic Lung Cancer from WCLC 2025
Read time: 3 minutes. For people with advanced or metastatic non-small cell lung cancer (NSCLC), the treatment landscape has changed dramatically in recent years. Researchers are -
Biggest News in Early-Stage Lung Cancer Research from WCLC 2025
Read time: 2 minutes. The annual World Conference on Lung Cancer (WCLC), organized by the International Association for the Study of Lung Cancer, is the largest global meeting -
Small Cell Lung Cancer: Not Small Anymore
Read time: 3 minutes. Small cell lung cancer (SCLC) research continues to progress at an unprecedented rate. Exciting news emerged from the 2025 World Congress on Lung Cancer, with -
Exciting Early Detection Research is Underway
Read time: 2 minutes. The likelihood of surviving five years or more after a lung cancer diagnosis is 27%. 1 But if it is caught early, before spreading, the five-year survival